SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Johnson & Johnson’s Tremfya Reduces Axial Psoriatic Arthritis Symptoms in Phase 4 Trial

A Phase 4 trial found that Tremfya reduced symptoms of axial psoriatic arthritis.

JNJ

Related stories